I 115th CONGRESS 1st Session H. R. 1732 IN THE HOUSE OF REPRESENTATIVES March 27, 2017 Mr. Dent (for himself, Mr. Himes , and Mr. Barletta ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.

1. Short title This Act may be cited as the Synthetic Drug Control Act of 2017 . 2. Treatment of certain designer drugs as schedule I controlled substances (a) In general Not later than 180 days after the date of enactment of this Act, the Attorney General of the United States shall update schedule I under section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) to include, unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a substance listed in paragraphs (1) through (9), or which contains the salts, isomers, and salts of isomers thereof whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. The substances referred to in the preceding sentence are the following: (1) Phenylalkylamines The substances listed in this paragraph consist of the following phenylalkylamines: (A) 1-(4-Ethylphenyl)-2-(methylamino)-1-propanone. (B) 1-(4-Methoxyphenyl)-2-(methylamino)-1-propanone. (C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1-propanone. (D) 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-propanone. (E) 2-(Ethylamino)-1-phenyl-1-propanone. (F) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone. (G) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone. (H) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone. (I) 2-Amino-1-(4-fluorophenyl)propan-1-one. (J) 2-(Ethylamino)-1-(4-ethylphenyl)-1-propanone. (K) 2-(Dimethylamino)-1-phenyl-1-propanone. (L) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-butanone. (M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone. (N) 2-(Methylamino)-1-phenyl-1-butanone. (O) 2-(Methylamino)-1-(4-methylphenyl)-1-butanone. (P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-butanone. (Q) 1-(3,4-Dimethylphenyl)-2-(methylamino)-1-propanone. (R) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone. (S) 2-(Benzylamino)-1-(4-methylphenyl)-1-propanone. (T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone. (U) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-propanone. (V) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-butanone. (W) 1-(1,3-Benzodioxol-2-yl)-2-(N-hydroxy-N-methylamino)-1-propanone. (X) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-butanone. (Y) 2-(Ethyl(methyl)amino)-1-phenylbutan-1-one. (Z) 1-(4-Bromophenyl)-2-(methylamino)-1-propanone. (AA) 2-[Ethyl(methyl)amino]-1-phenyl-1-propanone. (BB) 2-(Methylamino)-1-(3-methylphenyl)-1-propanone. (CC) 2-(1-Pyrrolidinyl)-1-(2-thiophenyl)-1-pentanone. (DD) 1-(4-Fluorophenyl)-2-(methylamino)-1-butanone. (EE) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-butanone. (FF) 1-(4-Ethylphenyl)-2-(1-pyrrolidinyl)-1-butanone. (GG) 1-(4-Methoxy-3-methylphenyl)-2-(methylamino)-1-propanone. (HH) 2-(Ethylamino)-1-(3-methylphenyl)-1-propanone. (II) 2-Amino-1-(1H-indol-5-yl)-1-propanone. (JJ) 1-Phenyl-2-(1-piperidinyl)-1-butanone. (KK) 2-(Methylamino)-1-(2,4,5-trimethylphenyl)-1-propanone. (LL) 1-Phenyl-2-(1-pyrrolidinyl)-1-heptanone. (MM) 1-Phenyl-2-(1-pyrrolidinyl)-1-hexanone. (NN) 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone. (OO) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone. (PP) 1-(2-Fluorophenyl)-N-methyl-2-propanamine. (QQ) 1-(2-Fluorophenyl)-2-propanamine. (RR) 1-(3-Fluorophenyl)-2-propanamine. (SS) 1-(3-Fluorophenyl)-N-methyl-2-propanamine. (TT) 1-(4-Fluorophenyl)-2-propanamine. (UU) 1-(4-Fluorophenyl)-N-methyl-2-propanamine. (VV) 1-(4-Methylphenyl)-2-propanamine. (WW) N-Ethyl-N-methyl-1-phenyl-2-propanamine. (XX) 1-(1-Benzofuran-4-yl)-2-propanamine. (YY) 1-(1-Benzofuran-5-yl)-2-propanamine. (ZZ) 1-(2,3-Dihydro-1-benzofuran-5-yl)-2-propanamine. (AAA) 1-(1-Benzofuran-6-yl)-2-propanamine. (BBB) 1-(2,3-Dihydro-1-benzofuran-6-yl)-2-propanamine. (CCC) 1-(4-Methoxyphenyl)-N-methyl-2-propanamine. (DDD) N,N-Dimethyl-1-phenyl-2-propanamine. (EEE) 1-(2,3-Dihydro-1H-inden-5-yl)-2-propanamine. (FFF) 5,6,7,8-Tetrahydronaphtho[2,3-d][1,3]dioxol-6-amine. (GGG) 1-[4-(Methylsulfanyl)phenyl]-2-propanamine. (HHH) 1-(4-Chlorophenyl)-2-propanamine. (III) 1-(2,4,6-Trimethoxyphenyl)-2-propanamine. (JJJ) 1-(2,4,5-Trimethoxyphenyl)-2-propanamine. (KKK) 1-(2,5-Dimethylphenyl)-2-propanamine. (LLL) 1-(3,4-Dimethylphenyl)-2-propanamine. (MMM) N-(1-Phenyl-2-propanyl)-1-propanamine. (NNN) 1-(1,3-Benzodioxol-5-yl)-N,N-dimethyl-2-propanamine. (OOO) N-Ethyl-1-(4-methoxyphenyl)-2-propanamine. (PPP) 1-(1-Benzofuran-5-yl)-N-methyl-2-propanamine. (QQQ) 6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine. (RRR) 5-Iodo-2-indanamine. (SSS) N-Methyl-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine. (TTT) N-Methyl-2-indanamine. (UUU) 2-{4-[(2-Fluoroethyl)sulfanyl]-2,5-dimethoxyphenyl}ethanamine. (VVV) 2-(8-Bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)ethanamine. (WWW) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)ethanamine. (XXX) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine. (YYY) 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. (ZZZ) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine. (AAAA) 2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. (BBBB) 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine. (CCCC) 1-(8-Bromofuro[2,3-f][1]benzofuran-4-yl)-2-propanamine. (DDDD) 1-(4-Chloro-2,5-dimethoxyphenyl)-2-propanamine. (EEEE) 1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b′]difuran-4-yl)propan-2-amine. (FFFF) 1-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-2-propanamine. (GGGG) 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-propanamine. (HHHH) 1-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-2-propanamine. (IIII) 6-Chloro-1,2,3,4-tetrahydro-1-naphthalenamine. (JJJJ) N-Methyl-3-phenylbicyclo[2.2.1]heptan-2-amine. (KKKK) 1-(2-Methoxyphenyl)-N-methyl-2-propanamine. (LLLL) 2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethanamine. (MMMM) 4-Methyl-2-hexanamine. (NNNN) 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine. (OOOO) N-Methyl-1-(2-thienyl)-2-propanamine. (PPPP) 3-(Dimethylamino)-2,2-dimethylpropyl 4-aminobenzoate. (QQQQ) 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine. (RRRR) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanol. (2) Cannabimimetic agents The substances listed in this paragraph consist of the following cannabimimetic agents: (A) (4-Ethyl-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (B) 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone. (C) (2-Methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl)(2-naphthyl)methanone. (D) (1-Butyl-1H-indol-3-yl)(4-methoxyphenyl)methanone. (E) (1-Butyl-1H-indol-3-yl)(4-methyl-1-naphthyl)methanone. (F) [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthyl)methanone. (G) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-yl}(1-naphthyl)methanone. (H) 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone. (I) (2-Iodophenyl){1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (J) Adamantan-1-yl{1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (K) 1-Naphthyl(1-propyl-1H-indol-3-yl)methanone. (L) 5-[3-(1-Naphthoyl)-1H-indol-1-yl]pentanenitrile. (M) 3-(1-Naphthylmethyl)-1-pentyl-1H-indole. (N) (2-Methyl-1-propyl-1H-indol-3-yl)(1-naphthyl)methanone. (O) 1-Naphthyl[1-(4-penten-1-yl)-1H-indol-3-yl]methanone. (P) (4-Bromo-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (Q) (4-Fluoro-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (R) (1-Naphthyl)(1-phenyl-1H-indol-3-yl)methanone. (S) [1-(5-Chloropentyl)-1H-indol-3-yl](2-iodophenyl)methanone. (T) Adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone. (U) (2-Iodo-5-nitrophenyl){1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (V) {1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone. (W) [1-(Tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (X) N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide. (Y) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (Z) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (AA) [1-(3-Methylbutyl)-1H-indol-3-yl](1-naphthyl)methanone. (BB) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide. (CC) (1-Pentyl-1H-indol-3-yl)(4-propyl-1-naphthyl)methanone. (DD) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (EE) (4-Methyl-1-naphthyl)[1-(4-penten-1-yl)-1H-indol-3-yl]methanone. (FF) (2-Methoxy-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (GG) (3-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone. (HH) (4-Ethyl-1-naphthyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (II) 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate. (JJ) 1-(5-Fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide. (KK) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. (LL) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indole-3-carboxamide. (MM) (2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone. (NN) [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](1-naphthyl)methanone. (OO) N-(1-Naphthyl)-1-pentyl-1H-indole-3-carboxamide. (PP) [1-(5-Chloropentyl)-1H-indol-3-yl](4-methyl-1-naphthyl)methanone. (QQ) (4-Methyl-1-naphthyl)(2-methyl-1-pent-4-enyl-1H-indol-3-yl)methanone. (RR) (2-Methylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (SS) (2-Ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (TT) [1-(5-Chloropentyl)-1H-indol-3-yl](1-naphthyl)methanone. (UU) [1-(5-Bromopentyl)-1H-indol-3-yl](1-naphthyl)methanone. (VV) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone. (WW) [1-(1-Methylazepan-2-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (XX) 4-Hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)-1-pentanone. (YY) [1-(4-Fluoropentyl)-1H-indol-3-yl](1-naphthyl)methanone. (ZZ) 2-(2-Iodophenyl)-1-(1-pentyl-1H-indol-3-yl)-1-ethanone. (AAA) (2,2,3,3-Tetramethylcyclopropyl)(1-butyl-1H-indol-3-yl)methanone. (BBB) (2,2,3,3-Tetramethylcyclopropyl)[1-(4,4,4-trifluorobutyl)-1H-indol-3-yl]methanone. (CCC) 7-Methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3 -carboxamide. (DDD) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate. (EEE) 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate. (FFF) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (GGG) [1-(4-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (HHH) 1-Naphthyl(1-pentyl-1H-indazol-3-yl)methanone. (III) N-(1-Naphthyl)-1-pentyl-1H-indazole-3-carboxamide. (JJJ) 1-Naphthyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. (KKK) Methyl 3-methyl-2-[(1-pentylindazole-3-carbonyl)amino]butanoate. (LLL) Methyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methylbutanoate. (MMM) N-Benzyl-1-pentyl-1H-indole-3-carboxamide. (NNN) N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (OOO) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate. (PPP) 8-Quinolinyl 1-pentyl-1H-indazole-3-carboxylate. (QQQ) 8-Quinolinyl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate. (RRR) 2-Naphthyl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate. (SSS) [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (TTT) 2-{[1-(5-Fluoropentyl)-1H-indol-3-yl]formamido}-3-phenylpropanamide. (UUU) 2-{[1-(5-Fluoropentyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide. (VVV) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3-methylbutanoate. (WWW) Methyl 2-[[1-(Cyclohexylmethyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. (XXX) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate. (YYY) [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](1-naphthyl)methanone. (ZZZ) [1-(4-Fluorobenzyl)-1H-indol-3-yl](1-naphthyl)methanone. (AAAA) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3,3-dimethylbutanoate. (BBBB) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate. (CCCC) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. (DDDD) N-(1-Amino-3-methyl-1-oxo-2-butanyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (EEEE) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-2-heptanyl)phenol. (FFFF) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-2-dodecanyl)phenol. (GGGG) 3-Hydroxy-2-[(1R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone. (HHHH) {4-[2,6-Dimethoxy-4-(2-methyl-2-octanyl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol. (IIII) 1-Naphthyl[4-(pentyloxy)-1-naphthyl]methanone. (JJJJ) 3-{[2-(Hydroxymethyl)-2,3-dihydro-1H-inden-4-yl]oxy}phenyl 4,4,4-trifluoro-1-butanesulfonate. (KKKK) N-(1,3-Benzodioxol-5-ylmethyl)-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxamide. (LLLL) N-[3-(2-Methoxyethyl)-4,5-dimethyl-2,3-dihydro-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropa ne-1-carboxamide. (MMMM) [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](1-naphthyl)methanone. (NNNN) 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide. (OOOO) 6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one. (PPPP) 4-Hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-3-(pentylamino)benzamide. (3) Arylcyclohexamines The substances listed in this paragraph consist of the following arylcyclohexamines: (A) 1-(3-Methoxyphenyl)-N-propylcyclohexanamine. (B) 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone. (C) 1-Phenylcyclohexanamine. (D) 1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine. (E) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine. (F) 1(4-Methoxyphenyl)-N-propylcyclohexanamine. (G) 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine. (H) 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine. (I) 1-Phenyl-N-propylcyclohexanamine. (J) N-(2-Methoxyethyl)-1-phenylcyclohexanamine. (K) N-(2-Ethoxyethyl)-1-phenylcyclohexanamine. (L) N-(3-Methoxypropyl)-1-phenylcyclohexanamine. (M) 3-[1-(1-Piperidinyl)cyclohexyl]phenol. (N) 2-(4-Methoxyphenyl)-2-(methylamino)cyclohexanone. (O) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone. (4) Tryptamines The substances listed in this paragraph consist of the following tryptamines: (A) 2-(1H-Indol-3-yl)-N-methylethanamine. (B) N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2-propanamine. (C) N-[2-(1H-Indol-3-yl)ethyl]-N-isopropyl-2-propanamine. (D) N-[2-(1H-Indol-3-yl)ethyl]-N-propyl-1-propanamine. (E) 3-(2-(Diethylamino)ethyl)-1H-indol-4-yl acetate. (F) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-ol. (G) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-yl acetate. (H) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-yl acetate. (I) 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate. (J) 3-[2-(Diethylamino)ethyl]-1H-indol-4-ol. (K) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-ol. (L) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-ol. (M) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate. (N) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-ol. (O) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl acetate. (P) N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-N-methylpropan-2-amine. (Q) 1-(5-Methoxy-1H-indol-3-yl)-2-propanamine. (R) 3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl acetate. (S) N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-2-amine. (T) N,N-Diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine. (U) N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethanamine. (5) Benzylpiperidines The substances listed in this paragraph consist of the following benzylpiperidines: (A) 2-(Diphenylmethyl)piperidine. (B) 2-(Diphenylmethyl)pyrrolidine. (C) Diphenyl(2-pyrrolidinyl)methanol. (D) Methyl (3,4-dichlorophenyl)(2-piperidinyl)acetate. (E) Methyl (3-chlorophenyl)(2-piperidinyl)acetate. (F) Methyl (4-methylphenyl)(2-piperidinyl)acetate. (G) Methyl (4-fluorophenyl)(2-piperidinyl)acetate. (H) Ethyl phenyl(2-piperidinyl)acetate. (6) Benzodiazepines The substances listed in this paragraph consist of the following benzodiazepines: (A) 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. (B) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one. (C) 8-Bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine. (D) 3-Methyl-6-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazine. (7) Opioids and opioid-like substances The substances listed in this paragraph consist of the following opioids and opioid-like substances: (A) 3-[2-(2-Amino-2-propanyl)-1-hydroxycyclohexyl]phenol. (B) 2-Methyl-N-phenyl-N-[1-(1-phenyl-2-propanyl)-4-piperidinyl]propanamide. (C) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine. (D) N-Phenyl-N-[1-(2-thiophenylethyl)-4-piperidinyl]acetamide. (8) Piperazines The substances listed in this paragraph consist of the following piperazines: (A) 1,4-Dibenzylpiperazine. (B) 1-(4-Bromo-2,5-dimethoxybenzyl)piperazine. (C) 1-(4-Fluorophenyl)piperazine. (D) 1-(2-Methoxyphenyl)piperazine. (E) 1-(4-Chlorophenyl)piperazine. (F) 1-(4-Methoxyphenyl)piperazine. (G) 1-(3-Methylbenzyl)piperazine. (H) 1-Benzyl-4-methylpiperazine. (9) Tropane and alkaloids The substances listed in this paragraph consist of the following tropane alkaloids: (A) 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoate. (B) Methyl 3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. (b) Inapplicability of other process and considerations The Attorney General of the United States may carry out subsection (a) without regard to the process and considerations that are otherwise applicable under section 201 of the Controlled Substances Act ( 21 U.S.C. 811 ) for adding, removing, or transferring controlled substances to, from, or among the schedules under section 202(c) of such Act ( 21 U.S.C. 812(c) ). (c) Exemption for research (1) Exemption Notwithstanding subsection (a), a material, compound, mixture, or preparation described in such subsection shall not be treated as a controlled substance for purposes of the Controlled Substances Act ( 21 U.S.C. 801 et seq.) so long as the material, compound, mixture, or preparation is manufactured, distributed, and used exclusively for qualified research. (2) Qualified research defined In this subsection, the term qualified research means research (as such term is used in section 303(f) of the Controlled Substances Act ( 21 U.S.C. 823(f) )) that is conducted by a practitioner who is registered under such section 303(f) to conduct research with controlled substances in schedule II, III, IV, or V (as described in such section 303(f)). (d) Rule of construction Nothing in this section shall be construed to limit or affect the authority of the Attorney General of the United States to add, remove, or transfer controlled substances to, from, or among the schedules under section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ), including controlled substances that have been added to a schedule pursuant to subsection (a).